Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 19 of 659 for:    applied AND web-

A Web Application for Improving Communication on Hemodialysis Rounds

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03605875
Recruitment Status : Recruiting
First Posted : July 30, 2018
Last Update Posted : November 29, 2018
Sponsor:
Information provided by (Responsible Party):
Stephanie Thompson, University of Alberta

Brief Summary:

To evaluate a web application tool that hemodialysis patients can use outside of dialysis time to log and prioritize their concerns for the nephrologists. Specifically, the investigators will compare the usability of a web application tool to a structured paper form. The investigators will also use data from semi-structured interviews to better understand the experience and acceptability of the web app among patient participants randomized to the web application and among participating nephrologists.

Primary outcome

-Usability (effectiveness, efficiency, satisfaction)

Secondary outcomes

-Quality of the patient-physician interaction (Communication Assessment Tool (CAT-14))


Condition or disease Intervention/treatment Phase
Hemodialysis Behavioral: Web-App Behavioral: Paper Phase 3

Detailed Description:

Usability is defined as Effectiveness (>70%)

  • Number of people submitting a concern/ number of people with opportunity to submit a concern
  • Number of concerns entered/number of times concern was satisfactorily addressed

Efficiency

  • Proportion of non-completed tasks (<70%)
  • The amount of time to complete one concern

Satisfaction

  • Semistructured interviews
  • Usability survey

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 90 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: 1:1 allocation
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Voicing Individual Concerns for Engagement in Hemodialysis (VOICE-HD): a Web Application for Rounds
Actual Study Start Date : November 28, 2018
Estimated Primary Completion Date : March 31, 2020
Estimated Study Completion Date : March 31, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Dialysis

Arm Intervention/treatment
Experimental: Web-App
A customized web-app tool to be used by patients to communicate concerns to their nephrologist
Behavioral: Web-App
Cambian IT Health solutions from Surrey BC developed the infrastructure

Active Comparator: Paper
A customized paper tool to be used by patients to communicate concerns to their nephrologist
Behavioral: Paper
Contains similar questions to the Web-App tool




Primary Outcome Measures :
  1. Effectiveness - Number of patients submitting a concern divided by the number of patients [ Time Frame: 8 weeks ]
    Number of patients submitting a concern divided by the number of patients with an opportunity to submit a concern

  2. Effectiveness - Number of concerns entered divided by the number of concerns that were satisfactorily addressed [ Time Frame: 8 weeks ]
    Number of concerns entered divided by the number of concerns that were satisfactorily addressed

  3. Efficiency - The amount of time to complete one concern [ Time Frame: 8 weeks ]
    The amount of time to log a concern in the web app

  4. Satisfaction - Usability survey [ Time Frame: 8 weeks ]
    Usability survey Defined as greater than 70% of users who agree or strongly agree with the statement on the usability survey. Ranked on a 5 -point Likert scale


Secondary Outcome Measures :
  1. Communication Assessment Tool [ Time Frame: 8 weeks ]
    Items rated from 1 (poor) to 5 (excellent). Published at Makoul et al. Patient Educ Couns 2007



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Chronic in-center hemodialysis patients in Edmonton, Alberta and Winnipeg, Manitoba
  • Able to provide consent, understand and read English or have a family member that can do this for them

Exclusion Criteria:

  • Planning to change modality within the next year

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03605875


Contacts
Layout table for location contacts
Contact: Sue Szigety 780 492 3330 sszigety@ualberta.ca
Contact: Nancy Ruholl 780 492 3887 nruholl@ualberta.ca

Locations
Layout table for location information
Canada, Alberta
Edmonton General Hospital Not yet recruiting
Edmonton, Alberta, Canada
Contact: Sue Szigety    780 492 3330    sszigety@ualberta.ca   
Royal Alexandra Hospital Recruiting
Edmonton, Alberta, Canada
Contact: Sue Szigety    780 492 3330    sszigety@ualberta.ca   
University of Alberta Hospital Recruiting
Edmonton, Alberta, Canada
Contact: Sue Szigety    780 492 3330    sszigety@ualberta.ca   
Canada, Manitoba
Seven Oaks General Hospital Recruiting
Winnipeg, Manitoba, Canada
Contact: Clara Bohm    204 787 3583      
Sponsors and Collaborators
University of Alberta
Investigators
Layout table for investigator information
Principal Investigator: Stephanie Thompson, MD PhD University of Alberta

Layout table for additonal information
Responsible Party: Stephanie Thompson, Assistant Professor, University of Alberta
ClinicalTrials.gov Identifier: NCT03605875     History of Changes
Other Study ID Numbers: Pro00076483
First Posted: July 30, 2018    Key Record Dates
Last Update Posted: November 29, 2018
Last Verified: November 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No